Every June the world commemorates the Fertility Care Month. Infertility is a disease that is estimated to affect 45 million people. A decrease in spontaneous birth rates has been proven globally, due to several factors: the participation of women in the labor market and access to family planning methods, added to the economic crises, the recent pandemic and the war in Europe.
This trend, in turn, is leveling out in all regions, accelerating year by year. Paradoxically, the use of assisted reproductive techniques is increasing exponentially throughout the world and particularly in times of crisis like the current one, given that people, beyond withdrawing, reinforce the will to get pregnant, especially patients who they are urged by the issue of age or simply by the force of desire.
Other aspects that contribute to this growth are the introduction and greater access to alternatives such as surrogacy for people with structural infertility problems who do not have the possibility of starting a family: single men, couples of men or women without a uterus.
Paying attention to reproductive age: a success for the future
On the other hand, there is greater awareness regarding the advanced reproductive age in women and its impact on oocyte quality, having the possibility of preserving fertility thanks to egg cryopreservation, and assisted reproduction or egg donation treatments in infertility cases.
To all this, we must add the contribution of reproductive genetics to improve the results and reduce the genetic risks in the offspring. That is why it is important to seek advice on today’s and future options. Today, with a simple procedure, the eggs can be frozen for future maternity, having the freedom on how and when to start a family.
We have more and more information on the human genome, which allows us to identify the causes of many more genetic diseases at an increasingly affordable cost. These studies can be carried out before seeking pregnancy or in the framework of assisted reproduction treatment, thanks to genetic studies on embryos generated in vitro, the so-called pre-implantation genetic study.
The health, economic and political crisis have brought forward the changes that were inexorably going to occur, driving an exponential growth of highly complex assisted reproduction treatments, egg cryopreservation and reproductive genetic studies.
The need arises to think about the future of the reproductive medicine with a more holistic, technological, medical and social look, incorporating fertility treatments as another method in family planning.
Medical Director of CEGyR, President of the Executive Committee of ALMER and Medical Specialist in Reproductive Medicine (MN75952).
David William is a talented author who has made a name for himself in the world of writing. He is a professional author who writes on a wide range of topics, from general interest to opinion news. David is currently working as a writer at 24 hours worlds where he brings his unique perspective and in-depth research to his articles, making them both informative and engaging.